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Abstract: Celiac disease (CD) is an immunological disorder that mainly affects the small
intestine, generating an inflammatory process in response to the presence of gluten (a protein).
Autoimmune diseases are part of a group of diseases that are difficult to diagnose without a specific
protocol or consensus to detect them due to the number of symptoms and diseases with which
it has a relationship. Therefore, the aim of this review was to analyze the diagnostic tools of CD
used in middle-aged women, to compare the use and effectiveness of the different tools, and to
propose a strategy for the use of the tools based on the results found in the literature. The present
research followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guideline. The search was conducted in the following databases: Scielo, PubMed, Web of Science,
and Worldwide Science org. In the initial literature search, 2004 titles and relevant abstracts were
found. Among them, 687 were duplicates, leaving 1130 articles. Based on the inclusion criteria,
only 41 articles passed the selection process; 4 main types of analyses appear in the studies: blood
tests, questionnaires, clinical history, and biopsy. It can be said that none of the analyses have a
100% reliability since most of them can present false negatives; therefore, the best way to diagnose
celiac disease up to now is through a combination of different tests (Immunoglobulin A and small
intestinal biopsy).
Keywords: diagnosis; diet; gluten; symptoms; women
1. Introduction
Celiac disease (CD) is an immunological disorder that mainly affects the small intestine,
generating an inflammatory process in response to the presence of gluten (a protein found mainly in
wheat, barley, and rye, among other contaminated foods like oatmeal) [1–4]. It is currently estimated
that 1% of the world population suffers from CD; it mainly occurs in women, with a probability of
2:1 [3,5]. The average age for diagnosis is around 45 years in Europe in the last 10 years; in Spain,
the last analysis said that most of the diagnoses occur in persons over 20 years. However, the average
does not mean that it cannot be diagnosed earlier; it means that, in this decade, more diagnoses
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happen around that age. Multiple factors can be related to the diagnosis age, such as no symptoms,
ignorance, or even no presence of intestinal inflammation [6]. This disease is related to weight variation,
hepatobiliary, and neurological or endocrine disorders, such as hypothyroidism [1]; it has also been
linked to problems of infertility and affects the absorption of nutrients such as calcium and vitamin
D (the main causes are the change in the small intestinal villi that can no longer absorb all vitamins
and nutrients and the lower vitamin D levels related to low exposure to sunlight that a large part of
the population experiences, whether due to changing seasons or to working in closed spaces for long
hours); therefore, CD is associated with the reduction of bone mass [7–10].
The only effective treatment is a gluten-free (strict) diet. With the disappearance of the symptoms,
the serology normalizes and the intestinal villi recover. The abandonment of treatment can cause
complications that, especially in adulthood, can manifest as osteopenia, osteoporosis, and high risk
of neoplasms in the digestive tract [11–13]. Also, the perception of the intensity of hot flushes and
irritability is more serious in celiac (undiagnosed or poorly treated) women with menopause [14] because
middle-aged women are the most affected by the consequences of not having a gluten-free diet amongst
people with celiac disease [14]. The investigation focuses on the studies conducted in this population
because, for different causes such as false negatives, a lot of celiac women are underdiagnosed.
Nutrition has an important role in these patients because a patient that fails to maintain a
gluten-free diet does not absorb the necessary nutrients which can then cause problems like anemia or
osteoporosis; this is because, when the patient consumes gluten, the nutrients are not absorbed by the
body because the reaction to gluten ends with a flat intestinal villus [15]. Also, constant cell division
could even result in malignant neoplasm caused by the renovation of intestinal cells more times than it
should in a normal life [15].
At the same time, all the tools that a health personnel should use to know the status of patients
in their entirety is not clear, since it involves not only the physical state but also the psychological
state and the disease damages multiple organs. Autoimmune diseases are part of a group of diseases
that are difficult to diagnose [16] because some of the symptoms are really common and the health
personnel does not request very invasive diagnostic tests or tests with high risks such as biopsies
without the patient having enough clear symptoms of the disease. In this disease, the clinical history
of the patients is very important to clarify symptoms that could go unnoticed [15,17,18]. Therefore,
a guide with different analyses can clarify the diagnosis and help avoid false negatives. Therefore,
our aim is to analyze the diagnostic tools of CD used in middle-aged women, to compare the use and
effectiveness of the different tools, and to propose a strategy for the use of the tools based on the results
found in the literature.
2. Materials and Methods
2.1. Data Sources and Searches
The present research followed the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guideline. The search was conducted from January 2018 until 1 May
2018 in the following databases: Scielo, PubMed, Web of Science, and WorldWide Science org.
The following MeSH (Medical Subject Headings, is the National Library of Medicine controlled
vocabulary thesaurus used for indexing articles for PubMed) [19] search headers were used: women
and celiac, coeliac, “gluten free”, or gluten. Subsequently, a second search was made on 25 February
2019. The eligibility criteria were predetermined by the authors. The search was registered on the
Prospero data base (Registration number CRD42019125224).
2.2. Inclusion and Exclusion Criteria
The inclusion criteria are the following: studies performed in celiac patients, published in scientific
journals, using tools to measure the health status of patients, which can be found as a full article,
published less than 10 years ago, written in English or Spanish, and performed on human beings.
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On the other hand, the exclusion criteria were the noninclusion of women, the study not containing
any measuring tool in celiac patients, the non-identification of a complete article, and the age of the
patients being less than 18 years. Retrieved articles were reviewed independently by two authors
(D.A.L.-M and A.M.) to choose potentially relevant articles; all disagreements were solved by a
third reviewer (J.A.R.A.). Two reviewers (D.A.L.-M and A.M.) independently extracted data from
the included studies. The following information was extracted: site and country of the study,
type of exercise, number of women included, age, tools or analysis used, and clinical characteristics.
This review’s target was a useful framework for thinking about patient outcomes attributable to
medical testing, and the focus was on outcomes that result from clinical management of CD based on
the test results and on the direct health effects or diagnosis of CD testing.
The variables reviewed were all those analyzed, and tools used to determine the health status of
a celiac woman and variables such as age, pathology, and gender of the patient were also reviewed.
The extraction of data was performed independently by P.S. and S.A., and conflicts were resolved by
consensus. The PEDro scale (an scale made to measure the quality of reports) was performed by the
reviewers (D.A.L.-M and A.M.) to all the selected articles.
2.3. Analisis of the Risk of Bias
One of the biases considered in this study was that of working with women since various male
symptoms are excluded from the study; in turn, as it is the group with the highest incidence and
problems caused, it makes sense to give special importance to their symptoms. Another likely bias is
the appearance of new methods and improved analyses in the last year, which could not be seen in this
study or in our approach.
Another risk of bias is the population (country and age) and the amount of persons in the studies
because, in the case of control, more tests could been made to compare with other studies but, in this
case, we are not comparing the results, only the methods.
In turn, it should be noted that the studies used also presented a risk of bias, since in some cases,
they had worked with the European population specifically or with cases treated in public hospitals
exclusively but we do not consider that they are an important bias for the meta-analysis.
3. Results
Characteristic of the Included Studies
In the initial literature search, 2004 titles and relevant abstracts were found. Among them,
687 were duplicates, leaving 1130 articles. A total of 860 were excluded based on abstracts and title
screening. Full texts were retrieved from the remaining 270 articles. Based on the inclusion criteria,
only 41 articles passed the selection process. Figure 1 shows the flow diagram of the study.
In Table 1, all the articles used for the review are presented, including the number of patients,
the journal impact index, the age of the participants, and the kind of tests that the studies used.
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Table 1. Characterization of the articles.
Study H Index Age Amount Analysis
Churruca et al. [19] 62 16 or + 54 Anthropometric measures, body composition, questionnaires, dietary assessment, serological testing, and intestinal biopsy
Stein et al. [20] 111 20–50 66 Serological testing, tomography, and densitometry
Turner et al. [9] 57 51 ± 16 32 Clinical history, anthropometric measures, densitometry, urine analysis, dietary intake, serological testing, and intestinal biopsy
Roos et al. [21] 13 20 or + 16 Interview and clinical history
Ehsani-Ardakani et al. [22] 18 32 ± 15 130 Clinical history and serum analysis
Fiolkova et al. [23] 14 NA NA Clinical history and analysis of literary sources
Rees [24] 45 +18 198 Clinical history and serum analysis
Peterson et al. [25] 27 NA NA Physical examination, serological testing, intestinal biopsy, and response to a GFD (Gluten Free Diet)
Belen Zanchetta et al. [26] 61 18–49 53 Serological testing and densitometry
Kocuvan Mijatov et al. [4] 7 23–76 40 Clinical history, questionnaires, and dietary assessment
Santonicola et al. [27] 93 +18 103 Clinical history and questionnaires
Jacobsson et al. [28] 47 20 or + 106 Clinical history and questionnaires
Passananti et al. [10] 42 20–60 95 Clinical history, serum analysis, and anthropometric measures
Fortunato et al. [29] 55 17–49 91 Clinical history
Zanchetta et al. [13] 74 19–50 31 Clinical history, serum analysis, and densitometry
Pinkerton et al. [30] 116 62 1 Clinical history, serum analysis, and densitometry
Jacobsson et al. [2] 47 30–75 54 Interview and clinical history
Singh et al. [31] 102 NA NA Clinical history
Tursi et al. [32] 52 22–37 13 Clinical history
Freeman [1] 82 NA NA Clinical history and analysis of literary sources
Duerksen et al. [33] 29 20 or + 376 Clinical history, serum analysis, and densitometry
Bykova et al. [34] 11 18 or + 217 Clinical history, serum analysis, and biopsy
Dhalwani et al[7] 142 25–29 2,426,225 Clinical history and analysis of literary sources
Sóñora et al. [35] 37 18–60 (36) 50 Clinical history and serum analysis
Sharshiner et al. [36] 30 30 ± 4.5 232 Clinical history and serum analysis
Ciacci et al. [37] 42 21–45 111 Clinical history, anthropometric measures, serological testing, and genetic analysis
Choi et al. [38] 18 25–39 191 Serological testing with hormones tests and intestinal biopsy
Moleski et al. [39] 24 +18 970 Clinical history, serological testing, intestinal biopsy, and questionnaire
Kavuncu et al. [40] 41 62.75 ± 8.58 192 Clinical history, body mass index, serological testing, biochemical analyses, and densitometry.
Fabbri et al. [41] 129 26 1 Clinical history, brain tomography, serological, biochemical analyses, and cardiovascular analysis.
Ludvigsson et al. [42] 212 Any age 107,124 Clinical history and biopsy
Sonora et al. [43] 37 29–47 10 Clinical history, serological tests, and immunostaining of placental tissue sections
Sultan et al. [44] 234 15–44 276,586 Clinical history
Stephansson et al. [45] 72 +18 66,089 Clinical history and biopsy
Martinelli et al. [46] 40 15–49 248 Clinical history, serum analysis, biopsy, and questionnaire
Tejera-Alhambra et al. [47] 85 29–44 79 Serum analysis
Hasan [48] – 24–46 50 Clinical history and serum analysis
Mohammadibakhsh et al. [49] 12 NA NA Clinical history, serum analysis, biopsy, questionnaire, and analysis of literary sources
Lasa et al. [8] 25 NA NA Clinical history, serum analysis, biopsy, questionnaire, and analysis of literary sources
Ludvigsson et al. [50] 114 16 or + 109,327 Clinical history, serum analysis, biopsy, and analysis of literary sources
Ludvigsson et al. [51] 112 NA 173,608 Clinical history, serum analysis, biopsy, and analysis of literary sources
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In 24 of the studies found, they used intestinal biopsy as the main source of diagnosis of
celiac disease, followed by blood tests of immunoglobulin A, anti-inflammatory transglutaminase,
and Immunoglobulin G [4,5,9,10,13,19,22,24,27,28,30–32,39–41,43,45,46,49–51]. The relevant
information was explained in the Table 2; Table 3.
Another of the least performed studies for the diagnosis of CD is the immunoassay metric [40];
in this, the level of antigens and antibodies is measured and they use the serum endomysia
antibody [1,19,20,22,33,35,37]. Different articles present that sensitivity to gluten or development of
CD were related to a genetic factor.
In the different studies, factors that help to measure fertility were measured, such as the
anti-Müllerian hormone, since we speak of middle-aged adult women [39]. They also used routine
physical examinations such as weight [5,7,10,20,26,27,32,51], height [5,7,10,20,26,27,32,51], body mass
index (BMI, a formula that uses weight and height) [5,7,10,20,26,27,32,51], fat mass, and energy
consumption [4,5], which were compared with their clinical analysis to be able to complement the
patient’s profile and to make a diagnosis. Analysis of the food consumed can also be found in order to
help the patient with his or her nutritional treatment, which is the only known treatment for CD [5].
Different tests that help the health personnel to know the physical and psychological states of the
patients with CD have been found in the different studies and is very important because it affects the
adherence to treatments for a good state of health [5,52,53].
In all the articles, the clinical history is an important document for diagnosis because it helps to
determine or find different symptoms that could be unnoticed by the patients; energy consumption
appears in a few studies to determine their nutrition, as do other data such as weight, body mass,
body mass index, and fat mass [15,17,18,54,55].
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Table 2. Diagnostic tests (invasive)/description of the different analyses and tests performed on patients and for what they are used.
Acronym Name Instrument for Objective Population Reference Values Characteristics
- Intestinal biopsy
Clinical diagnosis of
diseases like celiac
disease
Observe the tissue
People with an IgA *1
elevated and
symptomatic (celiac)
Healthy for celiac
disease: without the
presence of IgA
It is a surgical procedure by which a
sample is extracted from tissue to be
able to rule out the presence of different
pathologies
- Endoscopy Observe and obtaintissue samples
Observe and obtain
tissue samples
Population at risk or
symptomatic Normal cells
“It is a procedure that allows the doctor
to see the inside of your body”. [56]
IgA Immuno-globulin A
Helps clinical
diagnosis of diseases
like celiac disease
Measure the amount
of immunoglobulin A
in blood
Symptomatic people
(celiac)
Healthy: 70–350 mg
*5/dL *2 (0.70–3.50 g
*3/L*4)
It is measured in blood serum; it is done
through the test ELISA *5 and carries
few risks.
(This description is for IgA, tTg *6, IgG
*7, and IgM *8.)tTg Transglutaminaseanti-inflammatory
Helps clinical
diagnosis of diseases
like celiac disease
Measure the amount
of anti-inflammatory
transglutaminase in
blood
Symptomatic people
(celiac)
They are not specified
as they depend on the
laboratory and
population.
IgG Immunoglobulin G
Helps clinical
diagnosis of diseases
like celiac disease
Measure the amount
of immunoglobulin G
Symptomatic people
(celiac)
Healthy: 700–1,700
mg/dL (7.0–17.0 g/L)
IgM Immunoglobulin M
Helps clinical
diagnosis of diseases
like celiac disease
Measure the amount
of immunoglobulin M
Symptomatic people
(celiac)
Will depend on the
laboratory that
performs the test
- Metabolomics
Helps clinical
diagnosis of diseases
like celiac disease
Measure and study of
small molecules
Symptomatic people
(celiac)
Presence or absence of
certain molecules and
proteins for example
P-cresol sulfate.
“Is the systematic study of the small
molecular metabolites in a cell, tissue,
biofluid, or cell culture media that are
the tangible result of cellular processes
or responses to an environmental stress.”
[57]
IRMA *9
Immuno-radiometric
assay
Clinical diagnosis of
diseases like celiac
disease
Measure the amount
of antigen and labeled
antibodies
Symptomatic people Presence or absenceof antigens.
Using florescence, they are labeled with
radioactive isotopes of the antibodies in
order to find the antigen that is causing
the pathology.
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Table 2. Cont.
Acronym Name Instrument for Objective Population Reference Values Characteristics
- Genetic Study
Clinical diagnosis of
diseases with genetic
implication, like
celiac disease
Observe the
chromosomes Symptomatic people
Status of
chromosomes,
absence of mutations.
Uses blood cells to generate cell growth
and to be able to study multiple cells
during metaphase and, with this, being
able to observe the karyotype of each
individual and study their DNA *9.
*1 Immunoglobulin A, *2 Deciliters, *3 Grams, *4 Litter, *5 Enzyme-Linked Immuno Sorbent Assay Milligrams, *6 Transglutaminase anti-inflammatory, *7 Immunoglobulin G, *8
Immunoglobulin M, *9 Immunoradiometric assay.
Table 3. Diagnostic tests (noninvasive)/description of the different analyses and tests performed on patients and for what they are used.
Acronym Name Instrument for Objective Population Reference Values Characteristics
CSI *1
Celiac Symptom
Index
Monitoring of
symptoms
It is made up of sixteen items, 11
of which evaluate “specific
symptoms “and 5 evaluate
“general health”. [58]
Celiac More than 45 means It is a questionnaire-type test.
- Food Frequencyquestionnaire
Evaluation of the
eating habits
Measure the food groups
consumed and its frequency All the population WHO values
It is a type of test where the
frequency with which the
individual consumes certain
foods is evaluated.
MDS *2
Mediterranean Diet
Score
Evaluation of the
eating habits
compared with the
Mediterranean Diet.
Compares the patient’s intake
with that recommended in the
Mediterranean diet
All the population
The values are
between 0 and 55:
more points better
habits.
It is a questionnaire-type test.
*1 Celiac Symptom Index. *2 Mediterranean Diet Score.
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4. Discussion
It can be seen that, of the 41 articles found, the main diagnostic method of CD
is biopsy but not before subjecting the patient to blood tests that show an elevation of
immunoglobulins [4,5,9,10,20,22,24,26,27,30–32,37,39,41,43,45,46,49–51,58]. In Italy, a study shows
that the prevalence of spontaneous abortion in celiac women was higher than in non-celiac women [29].
Another study made in United States concluded that women with unexplained infertility have more
risk of having CD [38]. A meta-analysis published in 2014 concluded that undiagnosed CD is a risk
factor for infertility [8]. In a study made in the United Kingdom, it was concluded that celiac women
have the same possibilities of the present fertility problems [7].
As the biopsy is an invasive analysis which entails risks, some alternatives are proposed for those
patients who present symptoms: serological studies, biomarkers, and EMA (Endomysial antibodies)
analysis [59,60]. The biggest problem with EMA analysis is that it must be accompanied by serological
samples. On the other hand, biomarkers fail in 20% of cases; although they would be a great way to
detect CD, they are not yet sufficiently reliable [59,60].
When making a diagnosis of CD, it is very important to know if the patient
suffers from the different symptoms; since studies that diagnose CD are invasive
analyses [4,5,9,10,20,22,24,26,27,30–32,37,39,41,43,45,46,49–51,58]. Therefore, before requesting the
analyses, it is useful to perform a Celiac Symptom Index test to identify the symptoms apart from the
clear use of the clinical history; in this way, a better diagnosis can be made [57].
Metabolomics is an analysis that rapidly evolves and allows a metabolic “fingerprint” of patients
with celiac disease with low-invasive and low-risk tests, which in part have a low cost [56]. This
study uses different techniques, among the least invasive to diagnose celiac disease, we can find the
tests performed with feces, with the technique of PCR-DGGE (real-time polymerase chain reaction,
denaturing gradient gel electrophoresis) [61].
When talking about avoiding different diseases caused by the lack of treatment of CD; it is
important to consider the quality of life and the psychological state of the patients in addition to
compliance with the diet, since factors such as anxiety, depression, and poor quality of life can cause
patients to abandon their treatment or can interrupt them from time to time [5,52,53,58]. Despite this,
the tools to measure the psychological state of patients are generally not used due to lack of knowledge
or time while consulting. Therefore, studies in which they use this type of test try to promote its
use and make known the benefits of it. For all this, it is important that they are among the different
diagnostic tools in celiac disease.
To avoid false negatives in the diagnosis results for CD, the diet of the patient is important because
the gluten-free diet shows an improvement in all the analyses and could pass as negative. Because
of that, the patients to be analyzed should eat gluten the months before a biopsy or a blood test,
the main problem is the risk (malignant neoplasm) and the health issues that this carries (diarrhea,
malabsorption of nutrients, headaches, and anemia, for example).
During the search for articles, the reviewers (D.A.L.-M and A.M.) found a series of limitations,
such as articles that did not appear because they did not contain the word celiac disease since they
included it in immunological or intestinal diseases; the constant appearance of different tools for health
status analysis that are simply the old ones with different names; and the constant publication of new
articles that force us to be in constant education and to search for tools.
This study provides a guide to facilitate the diagnosis and to check the health status of middle-aged
celiac patients, thereby reducing the time of search for diagnosis, the amount of analysis, and with this,
the risks. With the guide, you can compare different tools and analyses, giving health staff the ease of
choosing the analysis that best suits your patient. It is important to know that the people without biopsy
cannot be diagnosed but they can be treated without the diagnosis to avoid complications. However,
we believe that more studies should be carried out in celiac patients to know their relationship with
the different pathologies and to be able to expand this guide, making it an aid for health personnel.
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Undiagnosed patients with celiac disease symptoms (like diarrhea, heath aches, stomach ache,
and anemia) but without the signs (like serological testing and biopsy) should try the gluten-free diet;
if his or her health improves, they should keep the gluten-free diet. The reason for this is because we
can find several people with silent celiac disease.
5. Conclusions
For all the above, it can be said that none of the analyses have a 100% reliability since most of
them can present false negatives; therefore, the best way to diagnose CD now is through a combination
of different tests such as a study of the patient’s diet, immunoglobulins, and intestinal biopsy. It is
expected that, for the future, metabolomics will improve its reliability from 80% to 99% or 100% since
it would facilitate the detection of this pathology. To ensure that we do not have false negatives,
the patient should eat gluten at least 2 months before the analysis is carried out.
At the same time, it is recommended that initially noninvasive methods be used for the detection
of symptoms as a food reminder or to test if the symptoms vary when stopping the consumption of
gluten; in this way, we can discard those patients whose symptoms do not decrease with the treatment.
It is recommended that health personnel use a diagnostic scheme like the one indicated in Figure 2 to
avoid inflammations and diseases generated by a lack of treatment of CD. With the scheme provided,
they can try to avoid false negatives and to improve the quality of life of patients.
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Figure 2. Flow diagram with the suggested steps to diagnose celiac disease. IgA: Immuno-globulin A,
IgG: Immuno-globulin G, IgM: Immuno-globulin G, tTg: Tra sglutaminase anti-infla matory. * I
case the patient has an evident improvement with the treatment (gluten-free diet), it will be continued;
otherwise, the presence of other pathologies should be studied.
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In turn, those patients who were already diagnosed with CD and suffer from other symptoms
may suffer from any of the related pathologies, such as osteoporosis, cardiovascular diseases,
hypothyroidism, etc. Due to this, we created some tables where the health professional can choose the
tests that help with the diagnosis of any pathology associated with CD, can try to decrease the search
for tests that facilitate the diagnosis, and can make an early treatment that allows the patient to attain a
quick recovery. An annual analysis with a food frequency questionnaire and a Celiac Symptom Index
questioner are also important, as they always remind the patient the importance of a gluten-free diet.
As a future line of research, it would be very useful to study the new diagnostic tests and to
compare them with intestinal biopsy, which is the diagnostic tool for its accuracy. In turn, psychological
analyses in this type of patient should be part of more studies, since they show the patient from another
very useful perspective so that health personnel can avoid treatment failure.
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